close
close

Breast Cancer Awareness Month: Addressing Racial Disparities in Detection, Treatment, and Outcomes

Breast Cancer Awareness Month: Addressing Racial Disparities in Detection, Treatment, and Outcomes

By Andrea Blue | The Seattle medium | Word In Black

This post was originally published on Seattle Medium

Credit: Susan G. Komen 3-Day/Unsplash

(WIB) – Every October, Breast Cancer Awareness Month is a compelling reminder of the progress made in the fight against breast cancer. Pink ribbons, walks and campaigns are vital to raise awareness and encourage early detection. Yet amid the sea of ​​pink, we must face a harsh reality: Racial disparities persist in breast cancer diagnosis, treatment, and outcomes. Women of color in the United States face higher death rates, delayed diagnosis, and less access to quality care than white women. This is not just a medical problem; it’s a matter of social justice.

Ahndrea Blue is the founder and president/CEO of the Making A Difference Foundation. (Courtesy photo)

Although the overall death rate from breast cancer has declined over the past few decades, these improvements have not been experienced equally across racial and ethnic groups. Black women, for example, are diagnosed with breast cancer at slightly lower rates than white women, but are 40% more likely to die from the disease. This disparity is particularly stark for triple-negative breast cancer, a more aggressive form of the disease that is disproportionately diagnosed in black women, a triple risk. Latina women also face unique challenges. They are more likely to be diagnosed with later-stage breast cancers, which limits treatment options and increases the likelihood of poor outcomes. Structural barriers such as language, immigration status, and lack of access to preventive health care further exacerbate these inequities.